SuperworthAngiodynamics shares outstanding ANGO
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Aug 31, 2026
- 42M
- On a year earlier
- +2.1%
- more shares
Angiodynamics had 42M diluted shares outstanding on average in Q1 FY27, the quarter to Aug 31, 2026.
That is 2.1% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2026 | 41.7M | +2% |
| FY2025 | 41M | +1% |
| FY2024 | 40.4M | +2% |
| FY2023 | 39.6M | +1% |
| FY2022 | 39.2M | +2% |
| FY2021 | 38.5M | +1% |
| FY2020 | 38.1M | +1% |
| FY2019 | 37.6M | −1% |
| FY2018 | 38.1M | +3% |
| FY2017 | 36.8M | +1% |
| FY2016 | 36.4M | +1% |
| FY2015 | 36M | +2% |
| FY2014 | 35.3M | +1% |
| FY2013 | 34.9M | +33% |
| FY2012 | 26.2M | +5% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q1 FY27 | 42M | +2% | |
| Q4 FY26 | 41.7M | +2% | |
| Q3 FY26 | 41.6M | +2% | |
| Q2 FY26 | 41.5M | +2% | |
| Q1 FY26 | 41.2M | +1% | |
| Q4 FY25 | 41M | +1% | |
| Q3 FY25 | 40.9M | +2% | |
| Q2 FY25 | 40.9M | +2% | |
| Q1 FY25 | 40.7M | +2% | |
| Q4 FY24 | 40.4M | +2% | |
| Q3 FY24 | 40.2M | +2% | |
| Q2 FY24 | 40.2M | +2% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Angiodynamics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.